Shiga Toxin-Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis.

PubWeight™: 1.53‹?› | Rank: Top 4%

🔗 View Article (PMID 26917812)

Published in Clin Infect Dis on February 24, 2016

Authors

Stephen B Freedman1,2, Jianling Xie2, Madisen S Neufeld2, William L Hamilton3, Lisa Hartling4, Phillip I Tarr5, Alberta Provincial Pediatric Enteric Infection Team (APPETITE), Alberto Nettel-Aguirre, Anderson Chuck, Bonita Lee, David Johnson, Gillian Currie, James Talbot, Jason Jiang, Jim Dickinson, Jim Kellner, Judy MacDonald, Larry Svenson, Linda Chui, Marie Louie, Martin Lavoie, Mohamed Eltorki, Otto Vanderkooi, Raymond Tellier, Samina Ali, Steven Drews, Tim Graham, Xiao-Li Pang

Author Affiliations

1: Section of Gastroenterology, Alberta Children's Hospital, Alberta Children's Hospital Research Institute.
2: Section of Pediatric Emergency Medicine, Alberta Children's Hospital, University of Calgary, Canada.
3: University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, United Kingdom.
4: Alberta Research Centre for Health Evidence, Department of Pediatrics, University of Alberta, Edmonton, Canada.
5: Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri.

Articles citing this

Whole Genome Sequencing for Genomics-Guided Investigations of Escherichia coli O157:H7 Outbreaks. Front Microbiol (2016) 0.78

The StcE metalloprotease of enterohaemorrhagic Escherichia coli reduces the inner mucus layer and promotes adherence to human colonic epithelium ex vivo. Cell Microbiol (2017) 0.76

Synchronous Disease Kinetics in a Murine Model for Enterohemorrhagic E. coli Infection Using Food-Borne Inoculation. Front Cell Infect Microbiol (2016) 0.75

Clinical Evaluation and Cost Analysis of the Great Basin Shiga Toxin Direct Molecular Assay for the Detection of Shiga Toxin-Producing Escherichia coli (STEC) in Diarrheal Stool Specimens. J Clin Microbiol (2016) 0.75

Mutation of the Enterohemorrhagic Escherichia coli Core LPS Biosynthesis Enzyme RfaD Confers Hypersusceptibility to Host Intestinal Innate Immunity In vivo. Front Cell Infect Microbiol (2016) 0.75

A Rapid Immunoassay for Detection of Shiga Toxin-Producing Escherichia coli Directly from Human Fecal Samples and Its Performance in Detection of Toxin Subtypes. J Clin Microbiol (2016) 0.75

Shiga Toxin Therapeutics: Beyond Neutralization. Toxins (Basel) (2017) 0.75

Mild Illness during Outbreak of Shiga Toxin-Producing Escherichia coli O157 Infections Associated with Agricultural Show, Australia. Emerg Infect Dis (2017) 0.75

Editorial Commentary: Increasing Evidence That Certain Antibiotics Should Be Avoided for Shiga Toxin-Producing Escherichia coli Infections: More Data Needed. Clin Infect Dis (2016) 0.75

Articles cited by this

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol (2010) 11.77

Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet (1983) 10.11

The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med (2000) 7.78

A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience. JAMA (1994) 4.85

Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis. JAMA (2002) 4.72

A severe outbreak of Escherichia coli O157:H7--associated hemorrhagic colitis in a nursing home. N Engl J Med (1987) 4.16

Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology. J Infect Dis (1990) 3.04

Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance. JAMA (1989) 2.73

Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study. J Pediatr (2002) 2.54

The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients. Clin Infect Dis (2001) 2.47

Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin I. Infection (1992) 2.35

Escherichia coli O157:H7, an emerging gastrointestinal pathogen. Results of a one-year, prospective, population-based study. JAMA (1988) 2.26

Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations. J Pediatr (1990) 2.16

Escherichia coli O157:H7 as the predominant pathogen associated with the hemolytic uremic syndrome: a prospective study in the Pacific Northwest. Pediatrics (1987) 1.98

Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics (1997) 1.90

Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents. Eur J Clin Microbiol Infect Dis (1998) 1.77

A nationwide case-control study of Escherichia coli O157:H7 infection in the United States. J Infect Dis (1998) 1.68

Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection. Clin Nephrol (1999) 1.68

Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain. Antimicrob Agents Chemother (2012) 1.62

Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. Clin Infect Dis (2012) 1.58

Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis. J Pediatr (1992) 1.56

Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4. JAMA (2012) 1.47

Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease. Toxins (Basel) (2010) 1.26

A continuing assessment of risk factors for the development of Escherichia coli O157:H7-associated hemolytic uremic syndrome. Clin Nephrol (1994) 1.22

Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome. Arch Pediatr Adolesc Med (2011) 1.19

Hemolytic Uremic Syndrome After an Escherichia coli O111 Outbreak. Arch Intern Med (2010) 1.18

Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection? Aliment Pharmacol Ther (2006) 1.18

Hemolytic uremic syndrome risk and Escherichia coli O157:H7. Emerg Infect Dis (2005) 1.12

Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota. Pediatr Infect Dis J (2012) 1.10

Escherichia coli O 157:H7-associated hemolytic-uremic syndrome after ingestion of contaminated hamburgers. J Pediatr (1994) 1.06

Role and clinical course of verotoxigenic Escherichia coli infections in childhood acute diarrhoea in Argentina. J Med Microbiol (2009) 0.99

Strategies for surveillance of pediatric hemolytic uremic syndrome: Foodborne Diseases Active Surveillance Network (FoodNet), 2000-2007. Clin Infect Dis (2012) 0.85

Ciprofloxacin reduces the risk of hemolytic uremic syndrome in patients with Escherichia coli O104:H4-associated diarrhea. Infection (2013) 0.82

Risk of hemolytic uremic syndrome from antibiotic treatment of Escherichia coli O157:H7 colitis. JAMA (2002) 0.82

[Hemorrhagic colitis caused by verotoxigenic Escherichia coli. Presentation of 9 cases]. Enferm Infecc Microbiol Clin (1996) 0.82

Risk of hemolytic uremic syndrome from antibiotic treatment of Escherichia coli O157:H7 colitis. JAMA (2002) 0.79

Does levofloxacin induce hemolytic uremic syndrome in patients infected with verotoxin-producing Escherichia coli O157 infections? Jpn J Infect Dis (2012) 0.78

Three years experience of adults admitted to hospital in north-east Scotland with E. coli O157. Scott Med J (2002) 0.77

Postdiarrheal hemolytic uremic syndrome in United States children: clinical spectrum and predictors of in-hospital death. J Pediatr (2015) 0.77

Risk of hemolytic uremic syndrome from antibiotic treatment of Escherichia coli O157:H7 colitis. JAMA (2002) 0.76

Articles by these authors

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol (2011) 21.49

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86

Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology (2003) 14.67

Identification of severe acute respiratory syndrome in Canada. N Engl J Med (2003) 14.29

The genome of the African trypanosome Trypanosoma brucei. Science (2005) 11.48

Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med (2005) 10.58

The American Board of Internal Medicine: evolving professional self-regulation. Ann Intern Med (2014) 7.65

The DNA sequence of the human X chromosome. Nature (2005) 6.97

Literature Review of Florida Red Tide: Implications for Human Health Effects. Harmful Algae (2004) 5.00

Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection. N Engl J Med (2002) 4.89

Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology (2006) 4.57

Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis (2004) 4.29

Norovirus illness is a global problem: emergence and spread of norovirus GII.4 variants, 2001-2007. J Infect Dis (2009) 4.25

Comparison of the 20-hour intravenous and 72-hour oral acetylcysteine protocols for the treatment of acute acetaminophen poisoning. Ann Emerg Med (2009) 3.67

Recommendations on screening for type 2 diabetes in adults. CMAJ (2012) 3.51

Initial evaluation of the effects of aerosolized Florida red tide toxins (brevetoxins) in persons with asthma. Environ Health Perspect (2005) 3.38

The preoperative incidence of raised intracranial pressure in nonsyndromic sagittal craniosynostosis is underestimated in the literature. J Neurosurg Pediatr (2014) 3.30

Occupational exposure to aerosolized brevetoxins during Florida red tide events: effects on a healthy worker population. Environ Health Perspect (2005) 3.27

Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin (2006) 3.21

Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection. Am J Gastroenterol (2005) 3.09

Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis (2002) 3.06

An investigation into human pandemic influenza virus (H1N1) 2009 on an Alberta swine farm. Can Vet J (2009) 3.03

Crystal structure of the cytoskeleton-associated protein glycine-rich (CAP-Gly) domain. J Biol Chem (2002) 3.01

Steroids and bronchodilators for acute bronchiolitis in the first two years of life: systematic review and meta-analysis. BMJ (2011) 3.00

A randomized trial of nebulized 3% hypertonic saline with epinephrine in the treatment of acute bronchiolitis in the emergency department. Arch Pediatr Adolesc Med (2009) 2.89

Ultralow thermal conductivity in disordered, layered WSe2 crystals. Science (2006) 2.79

An economic evaluation of activated protein C treatment for severe sepsis. N Engl J Med (2002) 2.69

Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study. Clin Infect Dis (2009) 2.63

Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis (2009) 2.59

Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. CMAJ (2006) 2.56

Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J Virol (2007) 2.35

Risk of injury associated with body checking among youth ice hockey players. JAMA (2010) 2.25

Does telephone triage delay significant medical treatment?: Advice nurse service vs on-call pediatricians. Arch Pediatr Adolesc Med (2003) 2.25

Caller satisfaction with after-hours telephone advice: nurse advice service versus on-call pediatricians. Pediatrics (2002) 2.24

The incidence of raised intracranial pressure in nonsyndromic sagittal craniosynostosis following primary surgery. J Neurosurg Pediatr (2015) 2.20

GBV-C/hepatitis G virus infection and non-Hodgkin lymphoma: a case control study. Int J Cancer (2010) 2.18

Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery. Crit Care Med (2003) 2.13

A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med (2013) 2.11

Core competencies in the science and practice of knowledge translation: description of a Canadian strategic training initiative. Implement Sci (2011) 2.09

Effect of a rapid response system for patients in shock on time to treatment and mortality during 5 years. Crit Care Med (2007) 2.04

Nicotinic acid limitation regulates silencing of Candida adhesins during UTI. Science (2005) 2.03

A 12-year prospective study of childhood herpes simplex encephalitis: is there a broader spectrum of disease? Pediatrics (2007) 2.03

Low salivary cortisol levels and externalizing behavior problems in youth. Dev Psychopathol (2005) 2.01

Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol (2006) 1.99

Global perspectives for prevention of infectious diseases associated with mass gatherings. Lancet Infect Dis (2012) 1.99

Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Lancet Neurol (2011) 1.92

Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology (2006) 1.89

Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. Am J Hum Genet (2002) 1.88

Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol (2007) 1.88

Reduced dosage of ERF causes complex craniosynostosis in humans and mice and links ERK1/2 signaling to regulation of osteogenesis. Nat Genet (2013) 1.87

Glycan receptor binding of the influenza A virus H7N9 hemagglutinin. Cell (2013) 1.84

Mutations in TCF12, encoding a basic helix-loop-helix partner of TWIST1, are a frequent cause of coronal craniosynostosis. Nat Genet (2013) 1.82

Comprehensive detection and serotyping of human adenoviruses by PCR and sequencing. J Clin Microbiol (2004) 1.81

Root traits predict decomposition across a landscape-scale grazing experiment. New Phytol (2014) 1.80

Cost effectiveness analysis in health care: contraindications. BMJ (2002) 1.80

Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation. Am J Respir Crit Care Med (2004) 1.78

Design and validation of real-time reverse transcription-PCR assays for detection of pandemic (H1N1) 2009 virus. J Clin Microbiol (2009) 1.76

Hot flashes and related outcomes in breast cancer survivors and matched comparison women. Oncol Nurs Forum (2002) 1.76

Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents. Expert Opin Biol Ther (2004) 1.76

Prevalence and complications of single-gene and chromosomal disorders in craniosynostosis. Pediatrics (2010) 1.73

Special care facility compared with traditional environments for dementia care: a longitudinal study of quality of life. J Am Geriatr Soc (2004) 1.71

Alternative methods of estimating an incubation distribution: examples from severe acute respiratory syndrome. Epidemiology (2007) 1.70

Reoperation for intracranial hypertension in TWIST1-confirmed Saethre-Chotzen syndrome: a 15-year review. Plast Reconstr Surg (2009) 1.68

Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial. Clin Infect Dis (2003) 1.67

Benefits of off-pump bypass on neurologic and clinical morbidity: a prospective randomized trial. Ann Thorac Surg (2003) 1.67

Increased detection of rotavirus using a real time reverse transcription-polymerase chain reaction (RT-PCR) assay in stool specimens from children with diarrhea. J Med Virol (2004) 1.66

Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature. Lung Cancer (2005) 1.65

Multiplex real time RT-PCR for the detection and quantitation of norovirus genogroups I and II in patients with acute gastroenteritis. J Clin Virol (2005) 1.64

A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis. Cancer Res (2009) 1.64

International multicenter investigation of LB20304, a new fluoronaphthyridone. Clin Microbiol Infect (1998) 1.60

Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea. Clin Infect Dis (2006) 1.59

A commutable cytomegalovirus calibrator is required to improve the agreement of viral load values between laboratories. Clin Chem (2009) 1.59

Pain assessment for children: overcoming challenges and optimizing care. Pediatr Emerg Care (2011) 1.59

Late neurologic and cognitive sequelae of inflicted traumatic brain injury in infancy. Pediatrics (2005) 1.59

Frontorhiny, a distinctive presentation of frontonasal dysplasia caused by recessive mutations in the ALX3 homeobox gene. Am J Hum Genet (2009) 1.57

Sexual dysfunction in women with ESRD requiring hemodialysis. Clin J Am Soc Nephrol (2012) 1.56

Health service costs for patients on the waiting list. Can J Surg (2002) 1.52

Outcomes among 3.5 million newly diagnosed hypertensive Canadians. Can J Cardiol (2013) 1.50

Interpretation of diagnostic laboratory tests for severe acute respiratory syndrome: the Toronto experience. CMAJ (2004) 1.50

Massive levothyroxine ingestion in a pediatric patient: case report and discussion. CJEM (2011) 1.48

Can volunteer community health workers decrease child morbidity and mortality in southwestern Uganda? An impact evaluation. PLoS One (2011) 1.47

Assessing the risk of laboratory-acquired meningococcal disease. J Clin Microbiol (2005) 1.47

Human herpesvirus 7 in pediatric hematopoietic stem cell transplantation. Pediatr Blood Cancer (2007) 1.46

Practice variations in the treatment of febrile infants among pediatric emergency physicians. Pediatrics (2009) 1.45

Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant (2005) 1.45

Does teaching crisis resource management skills improve resuscitation performance in pediatric residents?*. Pediatr Crit Care Med (2014) 1.44

Pediatric Epstein-Barr Virus-Associated Encephalitis: 10-Year Review. J Child Neurol (2006) 1.41

Wilderness Medical Society Roundtable Report. Recommendations on the use of epinephrine in outdoor education and wilderness settings. Wilderness Environ Med (2010) 1.40

Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival. BMC Med (2008) 1.40

A simplified, noninvasive stool DNA test for colorectal cancer detection. Am J Gastroenterol (2008) 1.40

A multidisciplinary community hospital program for early and rapid resuscitation of shock in nontrauma patients. Chest (2005) 1.39

Epstein-Barr virus in pediatric multiple sclerosis. JAMA (2004) 1.38

Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials. J Am Soc Nephrol (2004) 1.37

Neurocognitive, functional, and health outcomes at 5 years of age for children after complex cardiac surgery at 6 weeks of age or younger. Pediatrics (2007) 1.37

Underground signals carried through common mycelial networks warn neighbouring plants of aphid attack. Ecol Lett (2013) 1.37

An outbreak due to multiresistant Acinetobacter baumannii in a burn unit: risk factors for acquisition and management. Infect Control Hosp Epidemiol (2002) 1.36

Evaluation and validation of real-time reverse transcription-pcr assay using the LightCycler system for detection and quantitation of norovirus. J Clin Microbiol (2004) 1.36